Logo image
Lanthanide complexes on Ag nanoparticles: Designing contrast agents for magnetic resonance imaging
Journal article   Peer reviewed

Lanthanide complexes on Ag nanoparticles: Designing contrast agents for magnetic resonance imaging

Talha S Siddiqui, Ashish Jani, Florence Williams, Robert N Muller, Luce Vander Elst, Sophie Laurent, Fang Yao, Youssef Zaim Wadghiri and Marc A Walters
Journal of colloid and interface science, Vol.337(1), pp.88-96
2009
DOI: 10.1016/j.jcis.2009.04.096
PMID: 19527906
url
https://orbi.umons.ac.be/bitstream/20.500.12907/22999/1/MULLER-2009-12-journal.pdfView
Open Access

Abstract

Uptake of gadolinium by nitrilotriacetate tethered to the surface of a silver nanoparticle. The gadolinium containing colloid induces the relaxation of proton spins in aqueous solution. This paper describes colloidal particles that are designed to induce hyper-intensity contrast ( T 1 relaxation) in MRI. The contrast agents consist of discrete gadolinium complexes tethered to 10 nm diameter silver nanoparticles. The gadolinium complexes (1) [Gd(DTPA-bisamido cysteine)] 2− and (2) [Gd(cystine–NTA) 2] 3−, undergo chemisorption to particle surfaces through thiol or disulfide groups, respectively, to form two new contrast agents. The resulting nanoparticulate constructs are characterized on the basis of their syntheses, composition, spectra and contrast enhancing power. The average r 1 relaxivities of the of the surface bound complexes (obtained at 9.4 T and 25 °C) are 10.7 and 9.7 s −1 mM −1, respectively, as compared to 4.7 s −1 mM −1 for the clinical agent Magnevist TM. Correspondingly, the respective whole particle relaxivities are 27927 and 13153 s −1 mM −1.
Nanoparticles Silver Relaxivity MRI Monolayer protected Contrast Longitudinal relaxation

Details

Metrics

Logo image